“Serum Interleukin-39 As an Emerging Inflammatory Biomarker in Diabetes Mellitus: Evidence from ROC Curve Analysis”. Chemical Interactions, vol. 2, no. 1, Feb. 2026, https://doi.org/10.64354/4nx8w333.